Xiaoping Jin
Impact in
-
- Protease and Inhibitor Mechanisms
-
- Galectins and Cancer Biology
Papers in
-
- S100 Proteins and Annexins 11
- Peroxisome Proliferator-Activated Receptors 2
-
- Protease and Inhibitor Mechanisms 13
- Co-authors
- Xinwei He (8 shared papers)Xiaofei Hu (5 shared papers)Min Zhu (12 shared papers)Weiling Li (9 shared papers)Gregory J. Mize (1 shared paper)Eileen Turcott (1 shared paper)David Morris (1 shared paper)Bing Ruan (2 shared papers)
- Journals
- Scientific Reports (2 papers)Vascular Medicine (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Journal of the American Chemical Society (1 paper)CNS Drugs (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoping Jin
37 papers receiving 711 citations
Peers
Comparison fields: 5 of 101
- Cancer Research 87
- Immunology 119
- Molecular Biology 383
- Oncology 91
- Cardiology and Cardiovascular Medicine 65
Countries citing papers authored by Xiaoping Jin
This map shows the geographic impact of Xiaoping Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Jin more than expected).
Fields of papers citing papers by Xiaoping Jin
This network shows the impact of papers produced by Xiaoping Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Jin. The network helps show where Xiaoping Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 93 | |
| 2 | 2019 | 76 | |
| 3 | 2011 | 75 | |
| 4 | 2003 | 63 | |
| 5 | 2017 | 61 | |
| 6 | 2016 | 46 | |
| 7 | 2019 | 41 | |
| 8 | 2012 | 38 | |
| 9 | 2017 | 32 | |
| 10 | 2017 | 20 | |
| 11 | Celastrol may have an anti-atherosclerosis effect in a rabbit experimental carotid atherosclerosis model. | 2014 | 18 |
| 12 | 2011 | 15 | |
| 13 | 2018 | 11 | |
| 14 | 2016 | 9 | |
| 15 | 2022 | 9 | |
| 16 | The association between the FABP2 Ala54Thr variant and the risk of type 2 diabetes mellitus: a meta-analysis based on 11 case-control studies. | 2015 | 9 |
| 17 | 2013 | 8 | |
| 18 | 2011 | 8 | |
| 19 | 2023 | 8 | |
| 20 | 2025 | 7 |
About Xiaoping Jin
Xiaoping Jin is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Neurology, having authored 39 papers that have together received 713 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), S100 Proteins and Annexins (11 papers), Cerebrovascular and Carotid Artery Diseases (5 papers), Cerebrovascular and genetic disorders (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Acute Ischemic Stroke Management (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Cancer Research (87 citations), Immunology (119 citations), Molecular Biology (383 citations), Oncology (91 citations) and Cardiology and Cardiovascular Medicine (65 citations). Xiaoping Jin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xinwei He, Xiaofei Hu, Min Zhu, Weiling Li, Gregory J. Mize, Eileen Turcott, David Morris, Bing Ruan, Xiuwen Wang and Guo‐Rong Chen. Their work appears in journals such as Scientific Reports, Vascular Medicine, Clinical Chemistry and Laboratory Medicine (CCLM), Journal of the American Chemical Society and CNS Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.